Works matching DE "RAS oncogenes"

Results: 2072
    1
    2
    3

    Clinicopathological and molecular characterization of KRAS wild‐type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes.

    Published in:
    Journal of Pathology, 2025, v. 266, n. 3, p. 337, doi. 10.1002/path.6432
    By:
    • Toriyama, Kazuhiro;
    • Masago, Katsuhiro;
    • Shibata, Noriko;
    • Haneda, Masataka;
    • Kuwahara, Takamichi;
    • Natsume, Seiji;
    • Kobayashi, Shota;
    • Fujita, Yasuko;
    • Sasaki, Eiichi;
    • Yamao, Kenji;
    • Kawashima, Hiroki;
    • Shimizu, Yasuhiro;
    • Hara, Kazuo;
    • Yatabe, Yasushi;
    • Hosoda, Waki
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases.

    Published in:
    Journal of Personalized Medicine, 2025, v. 15, n. 5, p. 181, doi. 10.3390/jpm15050181
    By:
    • Garlin Politis, Michelle;
    • Mansukhani, Mahesh;
    • Herzberg, Benjamin O.;
    • Chen, Lanyi N.;
    • Stoopler, Mark;
    • Saliba, Maelle;
    • Siegelin, Markus;
    • Zhu, Zhe;
    • Sonett, Joshua;
    • Henick, Brian S.;
    • Cheng, Simon K.;
    • Acharyya, Swarnali;
    • Shu, Catherine A.;
    • Miller, Michael L.;
    • Izar, Benjamin;
    • Fernandes, Helen;
    • Hsiao, Susan;
    • Saqi, Anjali
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00838-4
    By:
    • Middleton, Gary;
    • Robbins, Helen L.;
    • Fletcher, Peter;
    • Savage, Joshua;
    • Mehmi, Manita;
    • Summers, Yvonne;
    • Greystoke, Alastair;
    • Steele, Nicola;
    • Popat, Sanjay;
    • Jain, Pooja;
    • Spicer, James;
    • Cave, Judith;
    • Shaw, Paul;
    • Gilligan, David;
    • Power, Danielle;
    • Fennell, Dean;
    • Bajracharya, Maya;
    • McBride, David J.;
    • Maheswari, Uma;
    • Frankell, Alexander M.
    Publication type:
    Article
    43
    44

    Driver mutations associated with signatures of platinum sensitivity in germ cell tumors.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00727-2
    By:
    • Sawa, Yun Cheng;
    • Jia, Liwei;
    • Krause, Harris;
    • Meagher, Margaret;
    • Millard, Frederick;
    • Elliott, Andrew;
    • Lafin, John T.;
    • Jamieson, Christina;
    • Antonarakis, Emmanuel S.;
    • D'Souza, Anishka;
    • Giannikou, Krinio;
    • Amatruda, James F.;
    • Daneshmand, Siamak;
    • McKay, Rana R.;
    • Oberley, Matthew;
    • Nabhan, Chadi;
    • Bagrodia, Aditya
    Publication type:
    Article
    45
    46

    Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00626-6
    By:
    • Zhao, Dan;
    • Li, Haiqing;
    • Mambetsariev, Isa;
    • Mirzapoiazova, Tamara;
    • Chen, Chen;
    • Fricke, Jeremy;
    • Wheeler, Deric;
    • Arvanitis, Leonidas;
    • Pillai, Raju;
    • Afkhami, Michelle;
    • Chen, Bihong T.;
    • Sattler, Martin;
    • Erhunmwunsee, Loretta;
    • Massarelli, Erminia;
    • Kulkarni, Prakash;
    • Amini, Arya;
    • Armstrong, Brian;
    • Salgia, Ravi
    Publication type:
    Article
    47

    Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00615-9
    By:
    • Nussbaum, Daniel P.;
    • Martz, Colin A.;
    • Waters, Andrew M.;
    • Barrera, Alejandro;
    • Liu, Annie;
    • Rutter, Justine C.;
    • Cerda-Smith, Christian G.;
    • Stewart, Amy E.;
    • Wu, Chao;
    • Cakir, Merve;
    • Levandowski, Cecilia B.;
    • Kantrowitz, David E.;
    • McCall, Shannon J.;
    • Pierobon, Mariaelena;
    • Petricoin III, Emanuel F.;
    • Joshua Smith, J.;
    • Reddy, Timothy E.;
    • Der, Channing J.;
    • Taatjes, Dylan J.;
    • Wood, Kris C.
    Publication type:
    Article
    48

    Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
    By:
    • Yousef, Abdelrahman;
    • Yousef, Mahmoud;
    • Chowdhury, Saikat;
    • Abdilleh, Kawther;
    • Knafl, Mark;
    • Edelkamp, Paul;
    • Alfaro-Munoz, Kristin;
    • Chacko, Ray;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Lee, Michael S.;
    • Willis, Jason;
    • Overman, Michael;
    • Doss, Sudheer;
    • Matrisian, Lynn;
    • Hurd, Mark W.;
    • Snyder, Rebecca;
    • Katz, Matthew H. G.
    Publication type:
    Article
    49

    Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
    By:
    • Yousef, Abdelrahman;
    • Yousef, Mahmoud;
    • Chowdhury, Saikat;
    • Abdilleh, Kawther;
    • Knafl, Mark;
    • Edelkamp, Paul;
    • Alfaro-Munoz, Kristin;
    • Chacko, Ray;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Lee, Michael S.;
    • Willis, Jason;
    • Overman, Michael;
    • Doss, Sudheer;
    • Matrisian, Lynn;
    • Hurd, Mark W.;
    • Snyder, Rebecca;
    • Katz, Matthew H. G.
    Publication type:
    Article
    50